LKFT — Lakefront Biotherapeutics NV
—
Nasdaq ·
Health Care ·
Pharmaceuticals ·
CIK 1421876 ·
Belgium
Last close
$28.02
Market Cap
—
52W High
$33.78
52W Low
$26.42
ADV30
174,040
Next earnings
—
No quarterly fundamentals indexed for this ticker.
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-301,599,000
Investing CF
$265,566,000
Financing CF
$-2,772,000
CapEx
$-8,732,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-2.11
As of
2026-06-07
Max Pain — expiry 2026-06-18 (volume-derived — Yahoo OI feed degraded)
max pain strike: $27.50 · spot: $28.02 · call volume: 0 · put volume: 35
Expected Move to 2026-06-18:
±$2.43
(8.67%) —
implied range
$25.59 –
$30.45
· ATM straddle on $27.50 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| LLY | ELI LILLY & Co | $1.01T | $1131.42 | — |
| JNJ | JOHNSON & JOHNSON | $560.33B | $232.77 | — |
| ABBV | AbbVie Inc. | $401.47B | $227.23 | — |
| MRK | Merck & Co., Inc. | $298.33B | $120.79 | — |
| AZN | ASTRAZENECA PLC | $288.38B | $185.95 | — |
News headlines (Yahoo Finance, 1h cache)
Gilead Sciences (GILD), Lakefront Biotherapeutics Acquire Ouro Medicines to Advance Autoimmune Pipeline
2026-06-07 04:39 · Yahoo
Gilead Sciences and Lakefront Complete Acquisition of Ouro Medicines to Further Expand Inflammation Pipeline
2026-06-04 20:15 · Yahoo
Lakefront Receives Transparency Notification from Bank of America
2026-05-26 20:01 · Yahoo
Lakefront Biotherapeutics NV (AMS:LKFT) Just Released Its First-Quarter Results And Analysts Are Updating Their Estimates
2026-05-10 06:01 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.